(Q39384319)

English

Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Promoter methylation status of VEGF receptor genes: a possible epigenetic biomarker to anticipate the efficacy of intracellular-acting VEGF-targeted drugs in cancer cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Jeeyeon Kim

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Junha Hwang

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Hyeseon Jeong

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Jieun Shin

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Gangmin Hur

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Young Woo Park

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Suk Hoon Lee

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Jei Kim

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

1 February 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

191-200

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22395469%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

VEGF as a therapeutic target in cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Sorafenib in advanced clear-cell renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Sunitinib versus interferon alfa in metastatic renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

VEGF-targeted therapy: mechanisms of anti-tumour activity.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Modes of resistance to anti-angiogenic therapy

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Vascular phenotype in angiogenic and non-angiogenic lung non-small cell carcinomas

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Drug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumors

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Inhibition of both paracrine and autocrine VEGF/ VEGFR-2 signaling pathways is essential to induce long-term remission of xenotransplanted human leukemias

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Vascular endothelial growth factor (VEGF) is an autocrine growth factor for VEGF receptor-positive human tumors.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

De novo expression of vascular endothelial growth factor in human pancreatic cancer: evidence for an autocrine mitogenic loop.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Expression of vascular endothelial growth factor receptors in human prostate cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Messenger RNA expression of vascular endothelial growth factor and its receptors in primary colorectal cancer and corresponding liver metastasis

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Autocrine stimulation of VEGFR-2 activates human leukemic cell growth and migration

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

SU11248, A selective tyrosine kinases inhibitor suppresses breast tumor angiogenesis and growth via targeting both tumor vasculature and breast cancer cells

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

AZD2171: a highly potent, orally bioavailable, vascular endothelial growth factor receptor-2 tyrosine kinase inhibitor for the treatment of cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

VEGF-Trap: a VEGF blocker with potent antitumor effects

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Angiogenesis as a therapeutic target

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Sunitinib-resistant gastrointestinal stromal tumors harbor cis-mutations in the activation loop of the KIT gene.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Mechanisms of resistance to imatinib and sunitinib in gastrointestinal stromal tumor.

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

PTK 787/ZK 222584, a tyrosine kinase inhibitor of all known VEGF receptors, represses tumor growth with high efficacy

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Sunitinib: a VEGF and PDGF receptor protein kinase and angiogenesis inhibitor

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

A multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Multiple targeted tyrosine kinase inhibition in the clinic: all for one or one for all?

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancer

1 reference

https://api.crossref.org/works/10.4161%2FEPI.7.2.18973

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39384319&oldid=1456244485"